Dishman Pharma Sept qtr net sales are anticipated to increase by 9percent

KR Choksey released its earning estimations on Pharma_sector for the qtr closed Sept 2011. Based on the research company, Dishman Pharma Sept qtr net sales are anticipated to increase by 9percent at Rs 254 cr, yoy, (Year-on-year) time frame.

The firm’s net gain is anticipated to decrease 50percent at Rs 15 cr cr on Year-on-year basis

Be Sociable, Share!
Tags:

Stock Market Basics For Beginners

Reason For Company Issue Shares To The Public

Reason For Company Issue Shares To The Public Most firms are generally began privately through their promoter(s). However, the promoters capital and also the borrowings from financial institutions as well as banks may ...…

Four Jumbo Rules of Stock Market Investing

Four Jumbo Rules of Stock Market Investing Choose the right company I have seen most people these days are looking for long term investments in Real Estate stocks like Unitech, DLF just because ...…

Initial Public Offer

Initial Public Offer Initial Public Offer. The initial sale of share by a firm for the public. The commonest reason for a firm to start an IPO is ...…

National Stock Exchange Of India (NSE)

National Stock Exchange Of India (NSE) National Stock Exchange (NSE), found in the 1990s as a demutualised electronic exchange by Indian financial institutions.  Today, NSE is India's biggest exchange and second ...…

Primary Markets?

Primary Markets? The market in which investors have the initial opportunity to buy a newly issued security ( IPO ). Companies and other groups obtain financing through ...…

Indian Share Tips

NSE Investment Site

Market Update

Share Guide

Designed by VMV
web
analytics